: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription

Articles published in Gastroenterology
Retrieve available abstracts of 374 articles:
HTML format

Single Articles

March 2024

IACUCCI M, Maeda Y, Ghosh S
A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
PubMed

MITEV S, Marinova C, Spassova Z
A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
PubMed

PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
Gastroenterology. 2024;166:409-434.
PubMed Abstract available

DULAI PS, Singh S, Jairath V, Wong E, et al
Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
Gastroenterology. 2024;166:396-408.
PubMed Abstract available

February 2024

KHROM M, Long M, Dube S, Robbins L, et al
Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
PubMed Abstract available

HERAUF M, Coward S, Pena-Sanchez JN, Bernstein CN, et al
A Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Towards Sustaining Healthcare Delivery.
Gastroenterology. 2024 Feb 18:S0016-5085(24)00178.
PubMed

MARILD K, Soderling J, Stephansson O, Axelrad J, et al
Histological remission in inflammatory bowel disease and female fertility: A nationwide study.
Gastroenterology. 2024 Feb 6:S0016-5085(24)00055.
PubMed Abstract available

KOCHAR B, Ananthakrishnan AN, Ritchie CS
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
Gastroenterology. 2024;166:235-239.
PubMed

HE S, Peng Y, Wei Q
Comments on "Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study".
Gastroenterology. 2024;166:356-357.
PubMed

LIU X, Prasath S, Siddiqui I, Walters TD, et al
Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic Histopathology.
Gastroenterology. 2024 Feb 1:S0016-5085(24)00119.
PubMed

January 2024

HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
PubMed Abstract available

KOSINSKY RL, Gonzalez MM, Saul D, Barros LL, et al
The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease.
Gastroenterology. 2024 Jan 9:S0016-5085(24)00009.
PubMed Abstract available

BARNES EL, Agrawal M, Syal G, Ananthakrishnan AN, et al
AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
Gastroenterology. 2024;166:59-85.
PubMed Abstract available

GILLILAND A, Chan JJ, De Wolfe TJ, Yang H, et al
Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
Gastroenterology. 2024;166:44-58.
PubMed Abstract available

EQUINOZZI E, O'Donnell M, Lee CD
A Woman With Pyoderma Gangrenosum, Recurrent Abdominal Pain, and Hematochezia.
Gastroenterology. 2024;166:31-35.
PubMed

SHEN X, Zhang Q, Zhang B
A 16-Year-Old Onset Case of Pancolitis With Rectovaginal and Rectovesical Fistulas.
Gastroenterology. 2024;166:e1-e5.
PubMed

December 2023

CAENEPEEL C, Falony G, Machiels K, Verstockt B, et al
Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease.
Gastroenterology. 2023 Dec 12:S0016-5085(23)05598.
PubMed Abstract available

ANANTHAKRISHNAN AN, Adler J, Chachu KA, Nguyen NH, et al
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.
Gastroenterology. 2023;165:1367-1399.
PubMed Abstract available

SEGAL JP
Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis.
Gastroenterology. 2023;165:1574-1575.
PubMed

November 2023

KOTLARZ DANIEL
Unveiling the protective role of BTNL-selected gammadelta T cells in inflammatory bowel disease.
Gastroenterology. 2023 Nov 28:S0016-5085(23)05566.
PubMed

DAVE M, Luther J, Briggs F
Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
Gastroenterology. 2023 Nov 7:S0016-5085(23)05223.
PubMed

WINE E
Could gut and food-derived yeast be responsible for activating T-cells in Crohn disease?
Gastroenterology. 2023 Nov 3:S0016-5085(23)05204.
PubMed

VENKATESWARAN N
Mirikizumab for the Management of Ulcerative Colitis.
Gastroenterology. 2023 Nov 3:S0016-5085(23)05206.
PubMed

October 2023

LEE HH, Singh S
Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.
PubMed

STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
PubMed Abstract available

YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Gastroenterology. 2023;165:963-975.
PubMed Abstract available

September 2023

CHEN J, Yang Q, Wang C
Multiple Hepatic Masses in a Patient with Crohn's disease.
Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
PubMed

KHANNA R
Upadacitinib for the Treatment of Crohn's Disease.
Gastroenterology. 2023 Sep 13:S0016-5085(23)05001.
PubMed

GANAPATHY A, Navale P, Mutch MG, Kim H, et al
Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression beyond inflammation.
Gastroenterology. 2023 Sep 12:S0016-5085(23)04997.
PubMed

LI Z, Chen Y, Ke H
Investigating the Causal Relationship between Gut Microbiota and Crohn's Disease: A Mendelian Randomization Study.
Gastroenterology. 2023 Sep 5:S0016-5085(23)04972.
PubMed

HUANG J, Chan SC, Fung YC, Mak FY, et al
Incidence, Risk Factors, and Temporal Trends of Small Intestinal Cancer: A Global Analysis of Cancer Registries.
Gastroenterology. 2023;165:600-612.
PubMed Abstract available

WINE E
Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?
Gastroenterology. 2023;165:802-803.
PubMed

August 2023

PEYRIN-BIROULET L, Allegretti JR, Rubin DT, Bressler B, et al
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Gastroenterology. 2023 Aug 31:S0016-5085(23)04963.
PubMed Abstract available

LELEIKO NS
Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".
Gastroenterology. 2023 Aug 7:S0016-5085(23)04882.
PubMed

KELM M, Flemming S
Surgical Resection Might Be the Preferred Therapy Option in Ileocecal Crohn's Disease.
Gastroenterology. 2023 Aug 4:S0016-5085(23)04840.
PubMed

DAMAS OM, Maldonado-Contreras A
Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease.
Gastroenterology. 2023;165:324-328.
PubMed

July 2023

MUKHERJEE PK, Nguyen QT, Li J, Zhao S, et al
Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
Gastroenterology. 2023 Jul 26:S0016-5085(23)04788.
PubMed Abstract available

LEWIS JD, Parlett LE, Jonsson-Funk ML, Brensinger C, et al
Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
Gastroenterology. 2023 Jul 15:S0016-5085(23)04776.
PubMed Abstract available

BAUMDICK ME, Niehrs A, Degenhardt F, Schwerk M, et al
HLA-DP on Epithelial Cells enables Tissue Damage by NKp44(+) NK Cells in Ulcerative Colitis.
Gastroenterology. 2023 Jul 14:S0016-5085(23)04772.
PubMed Abstract available

YAN F, Yang Y
First line treatment options for ileocecal Crohn's disease: Early surgical resection or Biologics?
Gastroenterology. 2023 Jul 3:S0016-5085(23)00933.
PubMed

DEEPAK P, Barnes EL, Shaukat A
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
Gastroenterology. 2023;165:11-15.
PubMed

GHUSN W, Acosta A, Kane S
An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy.
Gastroenterology. 2023;165:40-43.
PubMed

June 2023

GAO S, Zhu R, Zhu L
Toward the understanding of altered gut microbiome in Crohn's disease: cause or consequence.
Gastroenterology. 2023 Jun 23:S0016-5085(23)00883.
PubMed

AGRAWAL M, Ebert AC, Poulsen G, Ungaro RC, et al
Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
Gastroenterology. 2023 Jun 9:S0016-5085(23)00872.
PubMed Abstract available

HE S, Lei P, Kang W, Cheung P, et al
Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.
Gastroenterology. 2023;164:1137-1151.
PubMed Abstract available

ROSHANOV PS, Khanna R
Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy.
Gastroenterology. 2023;164:1336-1337.
PubMed

KILINCALP S, Mottacki N
A Shallow Large Ulcer on the Ileocecal Valve in a Young Man With Ulcerative Proctitis.
Gastroenterology. 2023;164:e16-e18.
PubMed

May 2023

RAYGOZA GARAY JA, Turpin W, Lee SH, Smith MI, et al
Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
Gastroenterology. 2023 May 30:S0016-5085(23)00805.
PubMed Abstract available

GHONEIM S
Etrasimod in ulcerative colitis.
Gastroenterology. 2023 May 11:S0016-5085(23)00725.
PubMed

ARMSTRONG H, Sigall-Boneh R, Wine E
This Letter to the Editor is in response to: Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
Gastroenterology. 2023 May 5:S0016-5085(23)00700.
PubMed

NEWMAN KL, Chedid VG, Boden EK
A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals.
Gastroenterology. 2023;164:866-871.
PubMed

April 2023

NOBLE AJ, Nowak JK, Adams AT, Uhlig HH, et al
Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.
Gastroenterology. 2023 Apr 14:S0016-5085(23)00619.
PubMed Abstract available

D'HAENS GR, Lee S, Taylor SA, Serone A, et al
Filgotinib for the Treatment of Small Bowel Crohn's Disease: the DIVERGENCE 1 Trial.
Gastroenterology. 2023 Apr 11:S0016-5085(23)00591.
PubMed

ALLEGRETTI JR, Mitsialis V, Canavan JB, Snapper SB, et al
Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.
Gastroenterology. 2023 Apr 6:S0016-5085(23)00584.
PubMed

FRAISSENON A, Desmurs-Clavel H, Guibaud L
Severe Chronic Rectocolitis Associated With a Characteristic Sunflower Magnetic Resonance Imaging Pattern.
Gastroenterology. 2023;164:529-532.
PubMed

GOWEN R, Gamal A, Di Martino L, McCormick TS, et al
Modulating the Microbiome for Crohn's Disease Treatment.
Gastroenterology. 2023;164:828-840.
PubMed Abstract available

March 2023

KAPPELMAN MD, Wohl DA, Herfarth HH, Firestine AM, et al
Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: a Pragmatic Randomized Trial.
Gastroenterology. 2023 Mar 31:S0016-5085(23)00538.
PubMed Abstract available

YANG Z, Qin J, Zhao L, Chen T, et al
Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease.
Gastroenterology. 2023 Mar 8:S0016-5085(23)00238.
PubMed Abstract available

IACUCCI M, Parigi TL, Del Amor R, Meseguer P, et al
Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis.
Gastroenterology. 2023 Mar 3:S0016-5085(23)00216.
PubMed Abstract available

SINGH S, Ananthakrishnan AN, Nguyen NH, Cohen BL, et al
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.
Gastroenterology. 2023;164:344-372.
PubMed Abstract available

NOVIELLO D, Facciotti F, Caprioli F
Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn's Disease.
Gastroenterology. 2023;164:500-501.
PubMed

February 2023

DE VOOGD F, D'Haens GR, Gecse KB
Response to Letters to the Editor regarding: "Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study, De Voogd et al.".
Gastroenterology. 2023 Feb 16:S0016-5085(23)00142.
PubMed

SHIN A, Kashyap PC
Promote or Prevent? Gut Microbial Function and Immune Status May Determine the Effect of Fiber in Inflammatory Bowel Disease.
Gastroenterology. 2023;164:182-184.
PubMed

RATH T, Atreya R, Bodenschatz J, Uter W, et al
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
Gastroenterology. 2023;164:241-255.
PubMed Abstract available

LIU Z, Alexander JL, Lin KW, Ahmad T, et al
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
Gastroenterology. 2023;164:300-303.
PubMed

WINE E
Eliminating Pathobionts With Bacteriophages: A Novel Approach to Reduce Gut Inflammation in Inflammatory Bowel Diseases?
Gastroenterology. 2023;164:304.
PubMed

RESEGOTTI A, Ribaldone DG
Is a Protective Stoma Mandatory in Anti-Tumor Necrosis Factor-Treated Crohn's Disease Patients Undergoing Surgery?
Gastroenterology. 2023;164:307.
PubMed

January 2023

ALLOCCA M, Kucharzik T, Rubin DT
Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is it Ready for Standard Practice?
Gastroenterology. 2023 Jan 25:S0016-5085(23)00054.
PubMed

KOTLARZ D
Identification of the gammadelta IEL-secreted Paneth cell protective factor API5 as a promising therapeutic target for ATG16L1-associated Crohn's disease.
Gastroenterology. 2023 Jan 18:S0016-5085(23)00046.
PubMed

NGUYEN V, Cominelli F, Chak A
Bowel Wall Layer Thickness in Ulcerative Colitis on Endoscopic Ultrasound.
Gastroenterology. 2023 Jan 16:S0016-5085(23)00041.
PubMed

LIVANOS AE, Dunn A, Fischer J, Ungaro RC, et al
Anti-integrin alphavbeta6 autoantibodies are a novel biomarker that antedate ulcerative colitis.
Gastroenterology. 2023 Jan 9:S0016-5085(23)00010.
PubMed Abstract available

ZHAO X, Yang W, Yu T, Yu Y, et al
Th17 Cell-Derived Amphiregulin Promotes Colitis-Associated Intestinal Fibrosis Through Activation of mTOR and MEK in Intestinal Myofibroblasts.
Gastroenterology. 2023;164:89-102.
PubMed Abstract available

PAPAMICHAEL K, Dubinsky MC, Cheifetz AS
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease.
Gastroenterology. 2023;164:164-165.
PubMed

December 2022

TANG J, Li Q, Chao K
A rare cause of rapid death in patients with Crohn's disease.
Gastroenterology. 2022 Dec 30:S0016-5085(22)01457.
PubMed

VERBURGT CM, Boneh RS, Dunn K
Reply to Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
Gastroenterology. 2022 Dec 20:S0016-5085(22)01394.
PubMed

MARCOVITCH L, Focht G, Carmon N, Tersigni C, et al
Development and validation of the TUMMY-UC, a Patient Reported Outcome for Pediatric Ulcerative Colitis.
Gastroenterology. 2022 Dec 17:S0016-5085(22)01390.
PubMed Abstract available

November 2022

LI Y, Pengbo S, Feng Y
A new evaluation method for remission of ulcerative colitis.
Gastroenterology. 2022 Nov 22:S0016-5085(22)01345.
PubMed

KUFTINEC GN, Lim JE, Yarur AJ
A Rare but Devastating Dermatologic Manifestation of Ulcerative Colitis.
Gastroenterology. 2022 Nov 3. pii: S0016-5085(22)01253.
PubMed

BALASUBRAMANIAM M, Nandi N, Aswani-Omprakash T, Sebastian S, et al
Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia.
Gastroenterology. 2022;163:1145-1150.
PubMed

GREEN PHR, Paski S, Ko CW, Rubio-Tapia A, et al
AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Gastroenterology. 2022;163:1461-1469.
PubMed Abstract available

DOLINGER MT, Dubinsky MC
The Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn's Disease Monitoring and Healing.
Gastroenterology. 2022;163:1166-1167.
PubMed

KHANNA R
Risankizumab for Induction and Maintenance of Remission in Crohn's Disease.
Gastroenterology. 2022;163:1470-1471.
PubMed

FOCHT G, Cytter-Kuint R, Greer MC, Pratt LT, et al
Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
Gastroenterology. 2022;163:1306-1320.
PubMed Abstract available

LEIBOVITZH H, Lee SH, Xue M, Raygoza Garay JA, et al
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
Gastroenterology. 2022;163:1364-1376.
PubMed Abstract available

WU N, Hong SK, Huang WF
Multiple Strictures of Small Intestine: Is It Crohn's Disease?
Gastroenterology. 2022;163:e1-e2.
PubMed

October 2022

WELZ L, Aden K
Fibrosis and Inflammation in Inflammatory Bowel Disease-More Than 2 Sides of the Same Coin?
Gastroenterology. 2022 Oct 29. pii: S0016-5085(22)01246.
PubMed

FORSS A, Ludvigsson JF, Olen O
Letter to the Editor regarding "The Rising Burden of Inflammatory Bowel Disease in Denmark over Two Decades: A Nationwide Cohort Study" by Agrawal et al.
Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01193.
PubMed

BOURGONJE AR
Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01194.
PubMed

PALMELA C, Maaser C
The use of intestinal ultrasound in ulcerative colitis - more than a mucosal disease?
Gastroenterology. 2022 Oct 9. pii: S0016-5085(22)01161.
PubMed

ALLEZ M
A CEACAM5-derived Peptide Activating CD8(+) Regulatory T Cells: A Future Option for Restoring Mucosal Homeostasis in Crohn's Disease?
Gastroenterology. 2022;163:822-824.
PubMed

SEGAL JP
Ustekinumab Versus Adalimumab in Patients With Crohn's Disease.
Gastroenterology. 2022;163:1115-1116.
PubMed

BRENNER TA, Steinway S
Penile Necrosis in a Patient With Untreated Crohn's Disease.
Gastroenterology. 2022;163:832-834.
PubMed

NGUYEN NH, Solitano V, Vuyyuru SK, MacDonald JK, et al
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Gastroenterology. 2022;163:937-949.
PubMed Abstract available

GLOBIG AM, Mayer LS, Heeg M, Andrieux G, et al
Exhaustion of CD39-Expressing CD8(+) T Cells in Crohn's Disease Is Linked to Clinical Outcome.
Gastroenterology. 2022;163:965-981.
PubMed Abstract available

DUNKIN D, Merlino F, Correale C, Yeretssian G, et al
A Small CEACAM5 Peptide Restores the Protective Function of CD8(+) Regulatory T Cells in Crohn's Disease.
Gastroenterology. 2022;163:1090-1093.
PubMed

GHIBOUB M, Penny S, Verburgt CM, Boneh RS, et al
Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
Gastroenterology. 2022;163:922-936.
PubMed Abstract available

September 2022

ARMSTRONG HK, Bording-Jorgensen M, Santer DM, Zhang Z, et al
Unfermented beta-fructan fibers fuel inflammation in select inflammatory bowel disease patients.
Gastroenterology. 2022 Sep 29. pii: S0016-5085(22)01150.
PubMed Abstract available

UNGARO RC, Kappelman MD
Reappraisal of COVID-19 Risk for Patients with Inflammatory Bowel Disease (IBD): Withdrawal of the British Society of Gastroenterology IBD Risk Grid.
Gastroenterology. 2022 Sep 23. pii: S0016-5085(22)01069.
PubMed

D'AMICO F, Peyrin-Biroulet L, Danese S
Is Selectivity the JAKpot Winner for Inflammatory Bowel Disease Treatment?
Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01065.
PubMed

HUA X, Ungaro RC, Petrick LM, Chan AT, et al
Inflammatory Bowel Disease is Associated with Prediagnostic Perturbances in Metabolic Pathways.
Gastroenterology. 2022 Sep 16. pii: S0016-5085(22)01061.
PubMed

PEKOW J
Fatigue in Inflammatory Bowel Disease: A Common Complaint With Few Answers.
Gastroenterology. 2022 Sep 5. pii: S0016-5085(22)01032.
PubMed

TURPIN W, Dong M, Sasson G, Raygoza Garay JA, et al
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Gastroenterology. 2022;163:685-698.
PubMed Abstract available

PIOVANI D, Hassan C, Repici A, Rimassa L, et al
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
Gastroenterology. 2022;163:671-684.
PubMed Abstract available

MORTHA A, Remark R, Del Valle DM, Chuang LS, et al
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Gastroenterology. 2022;163:659-670.
PubMed Abstract available

LE COSQUER G, Zadro C, Gilletta C
A Rare Pregnancy-related Complication of Crohn's Disease: Diagnosis and Treatment.
Gastroenterology. 2022;163:586-587.
PubMed

August 2022

DE VOOGD F, van Wassenaer EA, Mookhoek A, Bots S, et al
Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective cohort study.
Gastroenterology. 2022 Aug 24. pii: S0016-5085(22)00966.
PubMed Abstract available

CLEVELAND NK, Bressler B, Siegel CA
A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities.
Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00925.
PubMed

CHEN B, Zhong J, Li X, Pan F, et al
Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00918.
PubMed Abstract available

BELLUSCI L, Zahra FT, Hopkins DE, Salazar JC, et al
Durability of Immunity is low against SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 variants following second and third vaccination in children and young adults with Inflammatory Bowel Disease receiving biologics.
Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00920.
PubMed

AGRAWAL M, Christensen HS, Bogsted M, Colombel JF, et al
The rising burden of inflammatory bowel disease in Denmark over two decades: a nationwide cohort study.
Gastroenterology. 2022 Aug 8. pii: S0016-5085(22)00881.
PubMed Abstract available

TRUYENS M, Lobaton T, Ferrante M, Bossuyt P, et al
Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial.
Gastroenterology. 2022 Aug 5. pii: S0016-5085(22)00828.
PubMed Abstract available

ZOLLNER A, Koch R, Jukic A, Pfister A, et al
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases.
Gastroenterology. 2022;163:495-506.
PubMed Abstract available

July 2022

CROWLEY E, Griffiths AM, Jairath V
Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization.
Gastroenterology. 2022 Jul 15. pii: S0016-5085(22)00778.
PubMed

SPENCER EA, Dubinsky MC
Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease: HLA-DQA1*05 Testing for Immunogenicity to anti-TNF Remains Relevan
Gastroenterology. 2022 Jul 6. pii: S0016-5085(22)00748.
PubMed

WINE E
Expanding Links Between Gut Microbiota and Bowel Inflammation.
Gastroenterology. 2022;163:333-334.
PubMed

KUANG AG, Bahdi F, Shukla R
Unusual Skin Ulcerations in a Patient With Hematochezia.
Gastroenterology. 2022;163:e7-e9.
PubMed

MA C, Hanzel J, Panaccione R, Sandborn WJ, et al
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
Gastroenterology. 2022 Jul 1. pii: S0016-5085(22)00730.
PubMed Abstract available

June 2022

HOUNTONDJI L, Rudler F, Blanc P
An atypical cause of musculoskeletal pain in a patient with chronic inflammatory bowel disease.
Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00727.
PubMed

MURAMOTO Y, Nihira H, Shiokawa M, Izawa K, et al
Anti-integrin alphavbeta6 antibody as a diagnostic marker for pediatric patients with ulcerative colitis.
Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00631.
PubMed

RICCIUTO A, Rauter I, McGovern DPB, Mader RM, et al
Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
Gastroenterology. 2022;162:1815-1821.
PubMed

DELSUPEHE AM, Bourgain C, Bossuyt P
Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader.
Gastroenterology. 2022;162:1849-1851.
PubMed

HANZEL J, Ma C, Jairath V
Design of Clinical Trials for Mild to Moderate Crohn's Disease.
Gastroenterology. 2022;162:1800-1814.
PubMed

LIU CY, Girish N, Gomez ML, Dube PE, et al
Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis.
Gastroenterology. 2022;162:1975-1989.
PubMed Abstract available

D'HAENS GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Gastroenterology. 2022;162:1876-1890.
PubMed Abstract available

ZHU Z, Gao Z, Li K
Controversy of Preoperative Exposure to Tumor Necrosis Factor Inhibitors in Surgical and Infectious Complications of Inflammatory Bowel Disease.
Gastroenterology. 2022 Jun 1. pii: S0016-5085(22)00588.
PubMed

May 2022

TANG J, Wang JP, Chao K
An Unusual Cause of Chronic Pancreatitis in a Patient with Crohn's Disease.
Gastroenterology. 2022 May 18. pii: S0016-5085(22)00521.
PubMed

SABINO J
Understanding the Role of PUFAs in Crohn's Disease.
Gastroenterology. 2022;162:1590-1591.
PubMed

SANDBORN WJ, D'Haens GR, Reinisch W, Panes J, et al
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Gastroenterology. 2022;162:1650-1664.
PubMed Abstract available

SHODA T, Collins MH, Rochman M, Wen T, et al
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
Gastroenterology. 2022;162:1635-1649.
PubMed Abstract available

SCHWARZLER J, Mayr L, Vich Vila A, Grabherr F, et al
PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease.
Gastroenterology. 2022;162:1690-1704.
PubMed Abstract available

April 2022

CROSS RK, Keefer L
Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?
Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00454.
PubMed

MA J, Wang Y, Cao H
When neurology meets gastroenterology: an unusual case of ulcerative colitis.
Gastroenterology. 2022 Apr 27. pii: S0016-5085(22)00447.
PubMed

WILSON A, Kim RB
Correspondence: Failure to Achieve Target Drug Concentrations During Induction and Not HLA- DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease - Is HLADQA1*05 gone before it's here?
Gastroenterology. 2022 Apr 12. pii: S0016-5085(22)00367.
PubMed

COHEN BL, Fleshner P, Kane SV, Herfarth HH, et al
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients with Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
Gastroenterology. 2022 Apr 9. pii: S0016-5085(22)00359.
PubMed

IRVING PM, Gecse KB
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.
Gastroenterology. 2022;162:1512-1524.
PubMed Abstract available

PLEVRIS N, Lees CW
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
Gastroenterology. 2022;162:1456-1475.
PubMed Abstract available

STIDHAM RW, Takenaka K
Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?
Gastroenterology. 2022;162:1493-1506.
PubMed Abstract available

VERSTOCKT B, Parkes M, Lee JC
How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
Gastroenterology. 2022;162:1383-1395.
PubMed Abstract available

VERSTOCKT B, Bressler B, Martinez-Lozano H, McGovern D, et al
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
Gastroenterology. 2022;162:1370-1382.
PubMed Abstract available

WILKENS R, Dolinger M, Burisch J, Maaser C, et al
Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound.
Gastroenterology. 2022;162:1476-1492.
PubMed Abstract available

LE BERRE C, Ricciuto A, Peyrin-Biroulet L, Turner D, et al
Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last.
Gastroenterology. 2022;162:1424-1438.
PubMed Abstract available

KEEFER L, Bedell A, Norton C, Hart AL, et al
How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease?
Gastroenterology. 2022;162:1439-1451.
PubMed Abstract available

March 2022

VERSTOCKT S, Torres J, Verstockt B
THE ROAD TO PROGNOSTICATION? A FIVE-PROTEIN PANEL PREDICTING DISEASE COURSE IN INFLAMMATORY BOWEL DISEASE.
Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00289.
PubMed

FAIRBRASS KM, Gracie DJ, Ford AC
Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 years of Longitudinal Follow-up.
Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00265.
PubMed Abstract available

REVES J, Chapman TP, Satsangi J, Torres J, et al
Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?
Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00290.
PubMed

RABINOWITZ LG, Rabinowitz DG, Silver EM, Oxentenko AS, et al
Disparities persist in inclusion of female, pregnant, lactating, and older individuals in inflammatory bowel disease clinical trials.
Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00267.
PubMed

HAYASHI Y, Nakase H, Hisamatsu T
Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19?
Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00239.
PubMed

HU MD, Golovchenko NB, Burns GL, Nair PM, et al
gammadelta Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.
Gastroenterology. 2022;162:877-889.
PubMed Abstract available

GOBERT AP, Latour YL, Asim M, Barry DP, et al
Protective Role of Spermidine in Colitis and Colon Carcinogenesis.
Gastroenterology. 2022;162:813-827.
PubMed Abstract available

February 2022

PANES J, Colombel JF, D'Haens GR, Schreiber S, et al
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
Gastroenterology. 2022 Feb 25. pii: S0016-5085(22)00199.
PubMed Abstract available

HART A, Rubin DT
Entering the Era of Disease Modification in Inflammatory Bowel Disease.
Gastroenterology. 2022 Feb 11. pii: S0016-5085(22)00141.
PubMed

ABRAHAM C, Abreu MT, Turner JR
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
Gastroenterology. 2022 Feb 8. pii: S0016-5085(22)00125.
PubMed Abstract available

KHANNA R, Chande N, Marshall JK
Ozanimod for the Treatment of Ulcerative Colitis.
Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00088.
PubMed

EDELMAN-KLAPPER H, Zittan E, Bar-Gil Shitrit A, Rabinowitz KM, et al
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFalpha.
Gastroenterology. 2022;162:454-467.
PubMed Abstract available

SANDS BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, et al
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Gastroenterology. 2022;162:495-508.
PubMed Abstract available

STADNIK A, Wojcicki M, Milkiewicz P
Splenic Tumor in a Patient After Liver Transplantation.
Gastroenterology. 2022;162:e14-e15.
PubMed

January 2022

CLEVELAND NK, Torres J, Rubin DT
WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?
Gastroenterology. 2022 Jan 28. pii: S0016-5085(22)00077.
PubMed Abstract available

SPENCER EA, Stachelski J, Dervieux T, Dubinsky MC, et al
Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease.
Gastroenterology. 2022 Jan 10. pii: S0016-5085(22)00017.
PubMed

SEDANO R, Jairath V, Ma C, Sedano R, et al
Design of clinical trials for mild-to-moderate ulcerative colitis.
Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00004.
PubMed

PRATT M, Forbes JD, Knox NC, Van Domselaar G, et al
Colorectal cancer screening in IBD - can characterization of GI microbiome signatures enhance neoplasia detection?
Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00007.
PubMed Abstract available

KUENZIG ME, Fung SG, Marderfeld L, Mak JW, et al
Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review.
Gastroenterology. 2022 Jan 4. pii: S0016-5085(22)00002.
PubMed Abstract available

LEVINE I, Swaminath A, Roitman I, Sultan K, et al
COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.
Gastroenterology. 2022;162:349-350.
PubMed

SAKURABA A, Luna A, Micic D
Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
Gastroenterology. 2022;162:88-108.
PubMed Abstract available

SEDANO R, Hogan M, Mcdonald C, Aswani-Omprakash T, et al
Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
Gastroenterology. 2022;162:338-340.
PubMed

YANG W, Liu H, Xu L, Yu T, et al
GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.
Gastroenterology. 2022;162:150-165.
PubMed Abstract available

BECKER HEF, Penders J, Jonkers DMAE
Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations.
Gastroenterology. 2022;162:4-8.
PubMed

D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
Gastroenterology. 2022;162:26-31.
PubMed

ALTEPETER T, Wertheimer E, Lee JJ
Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
Gastroenterology. 2022;162:22-25.
PubMed

December 2021

LAMB CA, Saifuddin A, Powell N, Rieder F, et al
The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease.
Gastroenterology. 2021 Dec 14. pii: S0016-5085(21)04069.
PubMed Abstract available

TORRES J, Ungaro RC, Colombel JF
Is prevention the best way to modify inflammatory bowel disease? How close are we?
Gastroenterology. 2021 Dec 11. pii: S0016-5085(21)04071.
PubMed

D'AMICO F, Allocca M, Fiorino G
Positioning ozanimod in ulcerative colitis: restoring leukocyte traffic under control.
Gastroenterology. 2021 Dec 8. pii: S0016-5085(21)04063.
PubMed

DARGENIO VN, Cristofori F, Francavilla R
An unexpected guest in a patient with ulcerative colitis.
Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)04041.
PubMed

FAYE AS, Dodson JA, Shaukat A
Safety and Efficacy of Anti-TNF Therapy in Older Adults with Ulcerative Colitis: A New Path Forward.
Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03816.
PubMed

SHEEHAN JL, Cohen-Mekelburg S
Positioning infliximab and vedolizumab in the treatment of moderate-to-severe ulcerative colitis.
Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03815.
PubMed

CHAPMAN TP, Reves J, Torres J, Satsangi J, et al
Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
Gastroenterology. 2021;161:2057-2059.
PubMed

GOLD SL, Cohen-Mekelburg S
An Apple a Day Keeps the Doctor Away: The Effect of a Low-Fat, High-Fiber Diet on Quality of Life, Inflammation, and Dysbiosis in Patients with Ulcerative Colitis.
Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03810.
PubMed

LI X, Liang D, Huang B
Reply.
Gastroenterology. 2021;161:2066-2067.
PubMed

ZHANG B, Zhang S
The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease.
Gastroenterology. 2021;161:2065-2066.
PubMed

KUO WT, Zuo L, Odenwald MA, Madha S, et al
The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
Gastroenterology. 2021;161:1924-1939.
PubMed Abstract available

November 2021

DI NARZO AF, Houten SM, Kosoy R, Huang R, et al
Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.
Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03738.
PubMed Abstract available

BOLTON C, Smillie CS, Pandey S, Elmentaite R, et al
An integrated taxonomy for monogenic inflammatory bowel disease.
Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03737.
PubMed Abstract available

CAO Y, Wang Z, Yan Y, Ji L, et al
Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p.
Gastroenterology. 2021;161:1552-1566.
PubMed Abstract available

LEE SH, Turpin W, Espin-Garcia O, Raygoza Garay JA, et al
Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
Gastroenterology. 2021;161:1540-1551.
PubMed Abstract available

October 2021

SHAH SC, Itzkowitz SH
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03707.
PubMed

BEN-HORIN S, Novack L, Mao R, Guo J, et al
Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials.
Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03709.
PubMed Abstract available

SPIERA E, Agrawal M, Ungaro R
COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.
PubMed

KAPPELMAN MD, Weaver KN, Boccieri M, Firestine A, et al
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
Gastroenterology. 2021;161:1340-1343.
PubMed

LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
PubMed Abstract available

SASSON SC, Slevin SM, Cheung VTF, Nassiri I, et al
Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Gastroenterology. 2021;161:1229-1244.
PubMed Abstract available

XIAO L, Ma XX, Luo J, Chung HK, et al
Circular RNA CircHIPK3 Promotes Homeostasis of the Intestinal Epithelium by Reducing MicroRNA 29b Function.
Gastroenterology. 2021;161:1303-1317.
PubMed Abstract available

September 2021

CLEVELAND NK, Rai V, El Jurdi K, Rao SS, et al
ULCERATIVE COLITIS PATIENTS HAVE REDUCED RECTAL COMPLIANCE COMPARED WITH NON-IBD CONTROLS.
Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03564.
PubMed

SUGIMOTO S, Iwao Y, Shimoda M, Takabayashi K, et al
Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03563.
PubMed

COHEN NA, Silfen A, Rubin DT
Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
Gastroenterology. 2021 Sep 22. pii: S0016-5085(21)03535.
PubMed

KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
Clinical Guidelines for the Management of Inflammatory Bowel Disease.
Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.
PubMed

PANES J
Integrin inhibitors in inflammatory bowel disease: from therapeutic antibodies to small molecule drugs.
Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03495.
PubMed

KONDO A, Ma S, Lee MYY, Ortiz V, et al
Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease.
Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03480.
PubMed Abstract available

UNGARO RC, Brenner EJ, Agrawal M, Zhang X, et al
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry.
Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03490.
PubMed

ALLIN KH, Moayyedi P
Proton pump inhibitor use - a risk factor for inflammatory bowel disease or an innocent bystander?
Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03478.
PubMed

VAN DE GUCHTE M, Mondot S, Dore J
Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis.
Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03482.
PubMed Abstract available

ARGMANN C, Tokuyama M, Ungaro RC, Huang R, et al
Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension.
Gastroenterology. 2021 Sep 1. pii: S0016-5085(21)03472.
PubMed Abstract available

TURNER D, Hanauer SB
Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
Gastroenterology. 2021;161:798-800.
PubMed

SPARROW MP
Quantification of Digestive Disease Damage in Crohn's Disease, Are We There Yet With the Lemann Index?
Gastroenterology. 2021;161:800-802.
PubMed

PONSIOEN CY, de Jonge WJ
Feeding the Gut-Liver Axis in PSC: What Makes It Different from IBD?
Gastroenterology. 2021;161:1070-1071.
PubMed

SOFFER S, Kopylov U, Klang E
Artificial Intelligence for the Evaluation of Mucosal Healing in IBD: The Future is Here.
Gastroenterology. 2021;161:1073-1074.
PubMed

MURTHY SK, Feuerstein JD, Nguyen GC, Velayos FS, et al
AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review.
Gastroenterology. 2021;161:1043-1051.
PubMed Abstract available

LEWIS JD, Sandler RS, Brotherton C, Brensinger C, et al
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
Gastroenterology. 2021;161:837-852.
PubMed Abstract available

PARIENTE B, Torres J, Burisch J, Arebi N, et al
Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
Gastroenterology. 2021;161:853-864.
PubMed Abstract available

LE PH, Kuo CJ, Wu RC
Colonic Bluish-Black Patches in a 57-Year-Old Woman with Crohn's Disease.
Gastroenterology. 2021;161:e10-e11.
PubMed

August 2021

SANDBORN W, Mattheakis LC, Modi NB, Pugatch D, et al
PTG-100, an Oral alpha4beta7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
Gastroenterology. 2021 Aug 30. pii: S0016-5085(21)03463.
PubMed Abstract available

BARBERIO B, Massimi D, Cazzagon N, Zingone F, et al
Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03412.
PubMed Abstract available

POZDNYAKOVA V, Botwin GJ, Sobhani K, Prostko J, et al
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03360.
PubMed

KUWADA T, Shiokawa M, Seno H
Two novel autoantibodies in patients with ulcerative colitis.
Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03354.
PubMed

XIA B, Yang M, Nguyen LH, He Q, et al
Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of three prospective cohorts.
Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03350.
PubMed Abstract available

ROGLER G, Singh A, Kavanaugh A, Rubin DT, et al
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Gastroenterology. 2021 Aug 3. pii: S0016-5085(21)03337.
PubMed Abstract available

JONES JL, Tse F, Carroll MW, deBruyn JC, et al
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
Gastroenterology. 2021;161:681-700.
PubMed Abstract available

WONG SY, Dixon R, Martinez Pazos V, Gnjatic S, et al
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
Gastroenterology. 2021;161:715-718.
PubMed

SARTOR RB
Targeting Adaptive Immune Responses to Human Bacterial Flagellins in Crohn's Disease.
Gastroenterology. 2021;161:416-418.
PubMed

DUBINSKY MC, Collins R, Abreu MT
Challenges and Opportunities in IBD Clinical Trial Design.
Gastroenterology. 2021;161:400-404.
PubMed

ALEXANDER KL, Zhao Q, Reif M, Rosenberg AF, et al
Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
Gastroenterology. 2021;161:522-535.
PubMed Abstract available

FURFARO F, Solitano V, Danese S
An Unusual Case of Cardiac Involvement in Crohn's Disease.
Gastroenterology. 2021;161:431-433.
PubMed

July 2021

BERGEMALM D, Andersson E, Hultdin J, Eriksson C, et al
Systemic inflammation in pre-clinical ulcerative colitis.
Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03277.
PubMed Abstract available

MEDERACKE I, Wiestler M, Wedemeyer H
An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.
PubMed

LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
PubMed Abstract available

BEN-TOV A, Banon T, Chodick G, Kariv R, et al
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
PubMed

PAPA A, Gasbarrini A, Lopetuso LR
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
Gastroenterology. 2021;161:368-369.
PubMed

RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
Gastroenterology. 2021;161:8-14.
PubMed

DE A, Chen W, Li H, Wright JR, et al
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
Gastroenterology. 2021;161:211-224.
PubMed Abstract available

June 2021

TAKADA Y, Ishikawa T, Kawashima H
An unusual pancreatic mass with ductal disruption: benign or malignant?
Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03173.
PubMed

REINISCH W
PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
PubMed

BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
PubMed Abstract available

PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
PubMed Abstract available

HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.
PubMed

MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.
PubMed

NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.
PubMed

BARBERIO B, Buda A, Savarino EV
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
Gastroenterology. 2021;160:2626-2627.
PubMed

BEZZIO C, Saibeni S
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
Gastroenterology. 2021;160:2625-2626.
PubMed

MAGO S, Vaziri H, Tadros M
The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
Gastroenterology. 2021;160:2623-2625.
PubMed

PREIDIS GA, Su GL, Morgan RL
Reply.
Gastroenterology. 2021;160:2633-2635.
PubMed

STANGE EF, von Bunau R, Erhardt A
Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
Gastroenterology. 2021;160:2632.
PubMed

SHMIDT E, Ho EY, Feuerstein JD, Singh S, et al
Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Gastroenterology. 2021;160:2511.
PubMed

HO EY, Singh S, Terdiman JP
Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Gastroenterology. 2021;160:2557-2562.
PubMed

SINGH S, Proctor D, Scott FI, Falck-Ytter Y, et al
AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Gastroenterology. 2021;160:2512-2556.
PubMed Abstract available

Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn's Disease: Clinical Decision Support Tool.
Gastroenterology. 2021;160:2509-2510.
PubMed

FEUERSTEIN JD, Ho EY, Shmidt E, Singh H, et al
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Gastroenterology. 2021;160:2496-2508.
PubMed

LORZADEH A, Romero-Wolf M, Goel A, Jadhav U, et al
Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
Gastroenterology. 2021;160:2267-2282.
PubMed Abstract available

LI X, Liang D, Meng J, Zhou J, et al
Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
Gastroenterology. 2021;160:2303-2316.
PubMed Abstract available

EDELMAN-KLAPPER H, Schwartz E, Ben-Horin S
Visible Worms in a Crohn's Patient Treated with Infliximab.
Gastroenterology. 2021;160:e10-e11.
PubMed

May 2021

KHAN N, Mahmud N
Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
PubMed Abstract available

PAI N, Popov J, Hill L, Hartung E, et al
Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.
PubMed

STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.
PubMed

OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
Gastroenterology. 2021;160:2196-2197.
PubMed

SAHA S, Mara K, Pardi DS, Khanna S, et al
Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Gastroenterology. 2021;160:1961-1969.
PubMed Abstract available

April 2021

AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
PubMed Abstract available

RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
PubMed Abstract available

AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.
PubMed

SHEEHAN JL, Brandler J, Rice MD
A Case of Recurrent Hepatic Abscesses.
Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
PubMed

TAXONERA C, Alba C, Olivares D
What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
Gastroenterology. 2021;160:1901-1902.
PubMed

MAGRO F, Dias CC, Morato M
Aminosalicylates and COVID-19: Facts or Coincidences?
Gastroenterology. 2021;160:1884-1885.
PubMed

RODRIGUEZ-LAGO I, Alonso-Galan H, Cabriada JL
Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
Gastroenterology. 2021;160:1878-1880.
PubMed

RABINOWITZ LG, Kim MK, Wong SY
Farnesoid X Receptor Variant: A Sex-based Determinant of Crohn's Disease Progression.
Gastroenterology. 2021;160:1866-1867.
PubMed

SHORT SP, Pilat JM, Barrett CW, Reddy VK, et al
Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
Gastroenterology. 2021;160:1694-1708.
PubMed Abstract available

GETTLER K, Levantovsky R, Moscati A, Giri M, et al
Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
Gastroenterology. 2021;160:1546-1557.
PubMed Abstract available

QU JY, Li Z
Is It a Crohn's Disease?
Gastroenterology. 2021;160:1477-1478.
PubMed

March 2021

SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.
PubMed

SHIRAI T, Kakuta Y, Fujii H
Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.
PubMed

UNGER LW, Kaser A
Is IL-6 back in trans signalling for inflammatory bowel disease?
Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.
PubMed

SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
PubMed Abstract available

SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
PubMed Abstract available

VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.
PubMed

ILIEV ID, Cadwell K
Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
Gastroenterology. 2021;160:1050-1066.
PubMed Abstract available

LU R, Zhang YG, Xia Y, Zhang J, et al
Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
Gastroenterology. 2021;160:1269-1283.
PubMed Abstract available

KUMAR A, Priyamvada S, Ge Y, Jayawardena D, et al
A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
Gastroenterology. 2021;160:1240-1255.
PubMed Abstract available

AL-BAHLANI AQ, Kron CM, Hart L
Chronic Diarrhea in a Pediatric Patient after Bone Marrow Transplantation.
Gastroenterology. 2021;160:e10-e12.
PubMed

February 2021

BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
PubMed Abstract available

MA C, Sedano R, Almradi A, Casteele NV, et al
An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
PubMed Abstract available

KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
PubMed Abstract available

COHEN RD, Feuerstein JD, Rubin DT
REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.
PubMed

NOWAK JK, Kalla R, Satsangi J
SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.
PubMed

KHANNA R, Afif W
Ustekinumab for Ulcerative colitis.
Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.
PubMed

POTDAR AA, Dube S, Naito T, Li K, et al
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
Gastroenterology. 2021;160:809-822.
PubMed Abstract available

TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
Gastroenterology. 2021;160:935-937.
PubMed

PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
Gastroenterology. 2021;160:925-928.
PubMed

MELMED GY, Rubin DT, McGovern DPB
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
Gastroenterology. 2021;160:639-644.
PubMed

BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
Gastroenterology. 2021;160:797-808.
PubMed Abstract available

BARNES EL, Loftus EV Jr, Kappelman MD
Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
Gastroenterology. 2021;160:677-689.
PubMed Abstract available

CHUNG-YEE HUI R, Kuo KL, Yang TW
A Rare Skin Complication Associated With Crohn's Disease.
Gastroenterology. 2021;160:669-670.
PubMed

KUMAR A, Magro C, Lukin DJ
Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.
Gastroenterology. 2021;160:e3-e5.
PubMed

January 2021

ZILBAUER M, Heuschkel R
Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.
PubMed

MESERVE J, Singh S
Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.
PubMed

TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.
PubMed

RANDOLPH GJ, Czepielewski RS
Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.
PubMed

PINTO-SANCHEZ MI, Seiler C, Verdu EF
Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.
PubMed

BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
PubMed Abstract available

BHAT S, Farraye FA, Hayney MS, Caldera F, et al
How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
PubMed

KHAN N, Yang YX
Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.
PubMed

LEE JC, Lyons PA, McKinney EF
Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.
PubMed

LE BERRE C, Peyrin-Biroulet L
Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
PubMed Abstract available

CHEN E, Chuang LS, Giri M, Villaverde N, et al
Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
PubMed Abstract available

SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
Gastroenterology. 2021;160:287-301.
PubMed Abstract available

LEE M, Chang EB
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Gastroenterology. 2021;160:524-537.
PubMed Abstract available

KELLERMAYER R, van der Laan M
Validation of Predictive Models in Inflammatory Bowel Diseases.
Gastroenterology. 2021;160:21-22.
PubMed

NORSA L, D'Antiga L
Reply.
Gastroenterology. 2021;160:474-475.
PubMed

SAZONOVS A, Ahmad T, Anderson CA
Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
Gastroenterology. 2021;160:470-471.
PubMed

CASADEI C, Barberio B, Savarino E
A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
Gastroenterology. 2021;160:e1-e3.
PubMed

ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
Gastroenterology. 2021;160:317-330.
PubMed Abstract available

RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
Gastroenterology. 2021;160:403-436.
PubMed Abstract available

December 2020

UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.
PubMed

TIAN Y, Zuo L
Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.
PubMed

TSE CS, Deepak P, Papadakis K
Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.
PubMed

WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
PubMed Abstract available

SHIMIZU MS, Matsuo T, Mori N
A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.
PubMed

TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
PubMed Abstract available

DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
PubMed Abstract available

IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
PubMed Abstract available

WAUTERS L, Ceulemans M, Frings D, Lambaerts M, et al
Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia.
Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35552.
PubMed Abstract available

KIM ES, Tarassishin L, Eisele C, Barre A, et al
Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
PubMed Abstract available

VERSTOCKT B, Torres J
Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.
PubMed

GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
PubMed Abstract available

ROSEN MJ
Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
Gastroenterology. 2020;159:2025-2027.
PubMed

KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
Gastroenterology. 2020;159:2193-2202.
PubMed Abstract available

BANERJEE A, Herring CA, Chen B, Kim H, et al
Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
Gastroenterology. 2020;159:2101-2115.
PubMed Abstract available

TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
Gastroenterology. 2020;159:2092-2100.
PubMed Abstract available

COURTET A, Lemale J, Carra MC
Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
Gastroenterology. 2020;159:2030-2033.
PubMed

ANGELINO G, Francalanci P, Tambucci R
Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
Gastroenterology. 2020;159:e9-e11.
PubMed

November 2020

MAHADEVAN U, Long MD, Kane SV, Roy A, et al
Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
PubMed Abstract available

TAXONERA C, Fisac J, Alba C
Can COVID-19 trigger de novo inflammatory bowel disease?
Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.
PubMed

FAIRBRASS KM, Gracie DJ, Ford AC
In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.
PubMed

TORRES J, Riddle M, Colombel JF
Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.
PubMed

KOCHAR B, Ananthakrishnan AN
Reply.
Gastroenterology. 2020;159:1993-1994.
PubMed

ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
Gastroenterology. 2020;159:1982-1984.
PubMed

PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
Gastroenterology. 2020;159:1968-1971.
PubMed

HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
Gastroenterology. 2020;159:1955-1957.
PubMed

SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
Gastroenterology. 2020;159:1763-1777.
PubMed Abstract available

October 2020

NAITO T, Botwin GJ, Haritunians T, Li D, et al
Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
PubMed Abstract available

GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
Central reading of ulcerative colitis clinical trial videos using neural networks.
Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
PubMed Abstract available

BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.
PubMed

ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.
PubMed

GARG M, Christensen B, Lubel JS
Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
Gastroenterology. 2020;159:1623-1624.
PubMed

PARIGI TL, Bonifacio C, Danese S
Is It Crohn's Disease?
Gastroenterology. 2020;159:1244-1246.
PubMed

TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
Reply.
Gastroenterology. 2020;159:1626-1627.
PubMed

GORDON M, Guyatt G
Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
Gastroenterology. 2020;159:1209-1215.
PubMed

STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
Gastroenterology. 2020;159:1357-1374.
PubMed Abstract available

RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
Gastroenterology. 2020;159:1375-1389.
PubMed Abstract available

September 2020

KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
PubMed Abstract available

MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
PubMed Abstract available

PAUL S, Roblin X
The Nightmare Monitoring of JAKinhibs.
Gastroenterology. 2020;159:1188-1189.
PubMed

TILG H, D'Haens G
How to Manage Crohn's Disease After Ileocolonic Resection?
Gastroenterology. 2020;159:816-820.
PubMed

KANG JW, Yan J, Ranjan K, Zhang X, et al
Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
Gastroenterology. 2020;159:1051-1067.
PubMed Abstract available

KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
Gastroenterology. 2020;159:832-834.
PubMed

HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
Gastroenterology. 2020;159:984-998.
PubMed Abstract available

PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
Gastroenterology. 2020;159:884-903.
PubMed Abstract available

August 2020

STAHL E, Roda G, Dobbyn A, Hu J, et al
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
Gastroenterology. 2020;159:549-561.
PubMed Abstract available

POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
Gastroenterology. 2020;159:784-787.
PubMed

APOSTOLOV R, Tan N, Vasudevan A
Poor Bowel Preparation in Crohn's Disease.
Gastroenterology. 2020;159:440-442.
PubMed

July 2020

BERNSTEIN CN
New Biomarkers for Crohn's Disease.
Gastroenterology. 2020;159:30-32.
PubMed

UNO Y
Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
Gastroenterology. 2020;159:399.
PubMed

ARDALAN ZS, Sparrow M, Gibson PR
The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
Gastroenterology. 2020;159:399-400.
PubMed

PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
Gastroenterology. 2020;159:257-272.
PubMed Abstract available

EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
Gastroenterology. 2020;159:386-387.
PubMed

NAIR N, Austin C, Curtin P, Gouveia C, et al
Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
Gastroenterology. 2020;159:383-385.
PubMed

UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
Gastroenterology. 2020;159:139-147.
PubMed Abstract available

MULLIN GE, Chey WD, Crowe SE
The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
Gastroenterology. 2020;159:20-25.
PubMed

HEALY ME, Boege Y, Hodder MC, Bohm F, et al
MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
Gastroenterology. 2020;159:183-199.
PubMed Abstract available

TORRES J, Petralia F, Sato T, Wang P, et al
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Gastroenterology. 2020;159:96-104.
PubMed Abstract available

June 2020

SABINO J, Torres J
You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
Gastroenterology. 2020;158:2304-2305.
PubMed

ZIDAR N
Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
Gastroenterology. 2020;158:2313-2314.
PubMed

BOUHNIK Y, Louis E, Peyrin-Biroulet L
Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
Gastroenterology. 2020;158:2306-2307.
PubMed

KOLLEN L, Werner O, Gavotto A
Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
Gastroenterology. 2020;158:2055-2057.
PubMed

KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
Gastroenterology. 2020;158:2104-2111.
PubMed Abstract available

CROWLEY E, Warner N, Pan J, Khalouei S, et al
Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
Gastroenterology. 2020;158:2208-2220.
PubMed Abstract available

SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
Gastroenterology. 2020;158:2123-2138.
PubMed Abstract available

LOEBENSTEIN M, Schulberg JD
Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
Gastroenterology. 2020;158:2069-2071.
PubMed

May 2020

TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
PubMed Abstract available

OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
Gastroenterology. 2020;158:1554-1573.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.